Advertisement

Ads Placeholder
Loading...

Roche Holding AG

RHHVF•PNK
Healthcare
Drug Manufacturers - General
$403.29
$32.23(8.69%)
U.S. Market is Open • 15:39

Roche Holding AG (RHHVF) Stock Overview

Explore Roche Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap321B
P/E Ratio19.96
EPS (TTM)$20.24
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$377.47
3 Months$406.53
1 Year Target$321.34

RHHVF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Roche Holding AG (RHHVF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $321.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.96 and a market capitalization of 321B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
8.63%
1-Month Change
-10.83%
3-Month Change
-0.13%
6-Month Change
11.98%
Year-to-Date (YTD) Change
-0.13%
1-Year Change
24.42%
3-Year Change
41.90%
5-Year Change
21.27%
All-Time (Max) Change
591.24%

Contact Information

https://www.roche.com
41 61 688 11 11
Grenzacherstrasse 124, Basel, NaN, 4058

Company Facts

1,032,490 Employees
IPO DateFeb 13, 2009
CountryCH

Frequently Asked Questions